Internal Medicine, Infectious Disease · Marrero, LA
NPI
1588160766
Since 2018
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1111 Medical Center Blvd Ste S850
Marrero, LA, 70072
Phone (504) 349-6450
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
372 services
Medicare patients, 2024
85
Average age 69
Drug cost, 2024
$524K
462 prescriptions
Company payments, 2025
$467
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Erik L Meyers was code 99233 (hospital e&m - subsequent), 193 times for 51 patients. In total Erik L Meyers billed 372 services in 11 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 193 | 51 | $90.63 | $17K |
| 99223 Hospital E&M - Initial | Facility | 58 | 52 | $127.80 | $7,413 |
| 99232 Hospital E&M - Subsequent | Facility | 50 | 28 | $59.82 | $2,991 |
| 99214 Office E&M - Established | Facility | 27 | 16 | $74.40 | $2,009 |
By year: 2023 $6,129 for 73 services; 2024 $34K for 372 services.
Medicare prescription drug claims, 2024
In 2024, the drug Erik L Meyers prescribed most often to Medicare patients was Ceftriaxone (Ceftriaxone Sodium), with 47 prescriptions and refills. In total Erik L Meyers wrote 462 Medicare prescriptions that cost $524K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ceftriaxone Ceftriaxone Sodium | 47 | 47 | 11 | $5,605 |
| Doxycycline Hyclate Generic | 33 | 43 | 19 | $919 |
| Daptomycin Generic | 26 | 26 | Under 11 | $7,116 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 20 | 20 | Under 11 | $92K |
| Vancomycin Hcl Generic | 20 | 20 | Under 11 | $6,272 |
| Dovato Dolutegravir Sodium/Lamivudine | 19 | 19 | Under 11 | $54K |
| Cefepime Hcl Generic | 18 | 18 | Under 11 | $2,924 |
| Ethambutol Hcl Generic | 17 | 17 | Under 11 | $505 |
| Cefoxitin Cefoxitin Sodium | 15 | 15 | Under 11 | $1,903 |
| Imipenem-Cilastatin Sodium Imipenem/Cilastatin Sodium | 15 | 15 | Under 11 | $7,459 |
| Azithromycin Generic | 14 | 14 | Under 11 | $215 |
| Rifabutin Generic | 13 | 13 | Under 11 | $5,844 |
| Amikacin Sulfate Generic | 13 | 13 | Under 11 | $953 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 12 | 13 | Under 11 | $221 |
| Nuzyra Omadacycline Tosylate | 11 | 11 | Under 11 | $161K |
Brand drugs: 79 claims; generic drugs: 383 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Erik L Meyers $467 ($467 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $447.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.